Market Overview:
The global biomarkers market size reached US$ 56.78 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 124.05 Billion by 2027, exhibiting a growth rate (CAGR) of 12.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Biomarkers, also known as biological markers, are molecules or genes that are used as indicators of the health or status of an organ, tissue, or cell. In addition to blood and bodily fluids, biomarkers are also found in tissues. In the discovery and development of new drugs, biomarkers are used for risk assessment, molecular diagnostics, disease diagnosis, DNA fingerprinting, and eliminating complexity. As a result, they play a crucial role in improving the drug development process, drug validation and testing, sample preparation and assay development. Biomarkers are often integrated with key imaging technologies that can provide clear images of oncology tumors and other problems while also eliminating the possibility of radiation exposure during CT scans and MRI scans.
Biomarkers Market Trends:
The market is majorly driven by the rising incidences of numerous chronic diseases among the masses, particularly in the geriatric population. In addition to this, the increasing implementation of biomarkers in infectious disease diagnosis is propelling the market. Moreover, continual developments in biomarker-based diagnostics, such as biomarker signatures resulting in faster drug development, non-invasive testing, and early diagnosis, are also creating a positive market outlook. In line with this, the rapid utilization of biomarkers in the development of companion diagnostics to identify drug target molecules is providing an impetus to the market. Also, the escalating demand for personalized medicine, along with a paradigm shift toward biomarker studies from conventional pathophysiology and epidemiology methods, is fueling the market. Furthermore, a considerable rise in the number of contract research organizations facilitating cost-efficient clinical trials are creating a positive market outlook. Some of the other factors contributing to the market include extensive research and development (R&D) activities and the increasing medical expenditure.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global biomarkers market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, type, disease, application and end user.
Breakup by Product:
- Consumables
- Services
- Software
Breakup by Type:
- Efficacy Biomarkers
- Safety Biomarkers
- Validation Biomarkers
Breakup by Disease:
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Immunological Disorders
- Renal Disorders
- Others
Breakup by Application:
- Diagnostics
- Drug Discovery and Development
- Personalized Medicine
- Others
Breakup by End User:
- Pharmaceutical and Biotechnology Companies
- Diagnostic and Research Laboratories
- Hospitals and Specialty Clinics
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Charles River Laboratories International Inc., Epigenomics AG, Eurofins Scientific SE, Merck KGaA, Perkinelmer Inc., Qiagen N.V, Quanterix Corporation, SphingoTec GmbH and Thermo Fisher Scientific Inc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Product, Type, Disease, Application, End User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Agilent Technologies Inc., Bio-Rad Laboratories Inc., Charles River Laboratories International Inc., Epigenomics AG, Eurofins Scientific SE, Merck KGaA, Perkinelmer Inc., Qiagen N.V, Quanterix Corporation, SphingoTec GmbH and Thermo Fisher Scientific Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global biomarkers market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global biomarkers market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the disease?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global biomarkers market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Biomarkers Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Consumables
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Software
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Type
7.1 Efficacy Biomarkers
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Safety Biomarkers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Validation Biomarkers
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Disease
8.1 Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cardiovascular Disorders
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Neurological Disorders
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Immunological Disorders
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Renal Disorders
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Application
9.1 Diagnostics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Drug Discovery and Development
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Personalized Medicine
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by End User
10.1 Pharmaceutical and Biotechnology Companies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Diagnostic and Research Laboratories
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Hospitals and Specialty Clinics
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Agilent Technologies Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Bio-Rad Laboratories Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Charles River Laboratories International Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Epigenomics AG
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Eurofins Scientific SE
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Merck KGaA
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Perkinelmer Inc.
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Qiagen N.V
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Quanterix Corporation
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.10 SphingoTec GmbH
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Thermo Fisher Scientific Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
List of Figures
Figure 1: Global: Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Biomarkers Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Biomarkers Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Biomarkers Market: Breakup by Product (in %), 2021
Figure 5: Global: Biomarkers Market: Breakup by Type (in %), 2021
Figure 6: Global: Biomarkers Market: Breakup by Disease (in %), 2021
Figure 7: Global: Biomarkers Market: Breakup by Application (in %), 2021
Figure 8: Global: Biomarkers Market: Breakup by End User (in %), 2021
Figure 9: Global: Biomarkers Market: Breakup by Region (in %), 2021
Figure 10: Global: Biomarkers (Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Biomarkers (Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Biomarkers (Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Biomarkers (Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Biomarkers (Software) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Biomarkers (Software) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Biomarkers (Efficacy Biomarkers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Biomarkers (Efficacy Biomarkers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Biomarkers (Safety Biomarkers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Biomarkers (Safety Biomarkers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Biomarkers (Validation Biomarkers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Biomarkers (Validation Biomarkers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Biomarkers (Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Biomarkers (Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Biomarkers (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Biomarkers (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Biomarkers (Neurological Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Biomarkers (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Biomarkers (Immunological Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Biomarkers (Immunological Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Biomarkers (Renal Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Biomarkers (Renal Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Biomarkers (Other Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Biomarkers (Other Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Biomarkers (Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Biomarkers (Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Biomarkers (Drug Discovery and Development) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Biomarkers (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Biomarkers (Personalized Medicine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Biomarkers (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Global: Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Global: Biomarkers (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Global: Biomarkers (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Global: Biomarkers (Diagnostic and Research Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Global: Biomarkers (Diagnostic and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Global: Biomarkers (Hospitals and Specialty Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Global: Biomarkers (Hospitals and Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Global: Biomarkers (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Global: Biomarkers (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: North America: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: North America: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: United States: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: United States: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Canada: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Canada: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Asia-Pacific: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Asia-Pacific: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: China: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: China: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Japan: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Japan: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: India: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: India: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: South Korea: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: South Korea: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Australia: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Australia: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Indonesia: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Indonesia: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Others: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Others: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Europe: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Europe: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Germany: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Germany: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: France: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: France: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: United Kingdom: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: United Kingdom: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Italy: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Italy: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Spain: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Spain: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Russia: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Russia: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Others: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Others: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Latin America: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 89: Latin America: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Brazil: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 91: Brazil: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 92: Mexico: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 93: Mexico: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 94: Others: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 95: Others: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 96: Middle East and Africa: Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 97: Middle East and Africa: Biomarkers Market: Breakup by Country (in %), 2021
Figure 98: Middle East and Africa: Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 99: Global: Biomarkers Industry: SWOT Analysis
Figure 100: Global: Biomarkers Industry: Value Chain Analysis
Figure 101: Global: Biomarkers Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Biomarkers Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Biomarkers Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Biomarkers Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 4: Global: Biomarkers Market Forecast: Breakup by Disease (in Million US$), 2022-2027
Table 5: Global: Biomarkers Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 6: Global: Biomarkers Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 7: Global: Biomarkers Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 8: Global: Biomarkers Market: Competitive Structure
Table 9: Global: Biomarkers Market: Key Players